PHV-wordings
Here you will find safety-relevant information that must be implemented in the corresponding product information due to a PHV issues.
Due to the relaunch of the EMA website in December 2023, you will find the current links to the entries prior to December 01, 2023 at https://www.ema.europa.eu
Search narrowed by
Levofloxacin (i.v. and oral use) New
PSUR-outcome
|
23/07/2024
Further information and amendments to the product information can be found on the EMA website.
Baclofen (oral, for muscle spasticity indication) New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Acitretin New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Diclofenac (topical formulations) New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.